September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Degradation of Basement membrane Protein is Significantly Reduced in Glaucomatous Trabecular meshwork
Author Affiliations & Notes
  • Sanjoy K Bhattacharya
    Ophthalmology, Univ of Miami Miller Sch of Med, Miramar, Florida, United States
  • Teresia Carreon
    Ophthalmology, Univ of Miami Miller Sch of Med, Miramar, Florida, United States
  • Genea T Edwards
    Ophthalmology, Univ of Miami Miller Sch of Med, Miramar, Florida, United States
  • Footnotes
    Commercial Relationships   Sanjoy Bhattacharya, None; Teresia Carreon, None; Genea Edwards, None
  • Footnotes
    Support  NIH Grant EY016112, SECIM pilot grant from UF, RPB unrestricted grant to University of Miami.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sanjoy K Bhattacharya, Teresia Carreon, Genea T Edwards; Degradation of Basement membrane Protein is Significantly Reduced in Glaucomatous Trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2016;57(12):No Pagination Specified.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We tested the hypothesis that the basement membrane (BM) proteins undergo significantly reduced degradation in glaucomatous trabecular meshwork (TM).

Methods : To prepare basement membrane (BM) proteins, the TM was dissected from normal and glaucomatous cadaver eyes (n=10 each) and incubated in 1% sodium deoxycholate buffer containing 2% Triton X-100, 0.5% Tween-20, and 0.5% Genapol C-100 overnight. The detergent-insoluble BMs were separated by centrifugation (15000 xg) and transferred multiple times into new detergent. The BMs were then deglycosylated with heparitinase and chondroitinase ABC lyase (100 U/mL) for 3 h, then solubilized in 8 M urea/mercaptoethanol. The solubilized sample was separated on a 4−15% 1D SDS PAGE gel under reducing conditions. Bands were visualized with colloidal Coommassie blue gel stain according to the manufacturer′s protocol. The gel bands from normal and glaucomaotus TM derived BM preparations were trypsin digested and subjected to iTRAQ labeling following established procedures and were analyzed on a Q-exactive instrument. Western blot and immunohistochemistry (n=10 normal and glaucomatous eyes) was performed for selected proteins. The BM samples were also subjected to intact protein mass analyses using a MALDI-Orbitrap imaging mass spectrometer (IMS). The University of Miami Institutional Review Board deemed the anonymous use of cadaveric eye tissue to be exempt.

Results : The selected low abundance BM proteins (LTBP2, Gasdermin, Wolframin, Alpha-tectorin) show elevated levels in glaucomatous TM. Some of these proteins are known to be of low expression in other systems. Western blot and intact IMS analyses show that increased levels of these proteins (such as Wolframin, Collagen type IV) are comprised of full length molecular weight proteins. Intact collagen IV levels were 0.2 ± 0.05 and 0.5 ± 0.07 μg/5 μg total protein extracted in normal and glaucomatous TM respectively (mean ± standard deviation, p≤0.005). Taken together with the IMS results, our results are consistent with the decreased degradation of BM proteins in glaucomatous TM compared to controls and support our hypothesis.

Conclusions : Basement membrane protein degradation is significantly reduced in the glaucomatous TM for selected proteins thus supporting our hypothesis.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×